A study by a team of University of Lethbridge neuroscientists has shown that tactile stimulation shows much promise as a non-invasive method of slowing the onset of dementia in aging mice and could be an additional therapeutic intervention for people with Alzheimer’s disease.
January is Alzheimer’s Awareness Month and the Alzheimer Society encourages everyone to learn more about dementia and its impact on Canadians. Alzheimer’s disease (AD) is the most common form of dementia and represents a global health crisis.
Current treatment options only serve to slow the progression of the disease, not to cure or prevent it. That’s why researchers at the Canadian Centre for Behavioural Neuroscience are working hard to increase knowledge about what happens in the brain with AD and find more therapeutic treatments. A recent study by Drs. Bryan Kolb, Majid Mohajerani and their team points the way to a possible easily accessible treatment for AD in humans. Working with a mouse model of AD, the researchers found that tactile stimulation (TS) in the form of light massaging slowed the onset of AD.
